Jennifer Perry

COO

Equibles does not estimate personal net worth.

Get an email with a short summary when Bicycle Therapeutics PLC publishes a filing, an earnings call transcript or a press release.

Get BCYC alerts

About Jennifer Perry

Jennifer Perry is recorded as COO at Bicycle Therapeutics PLC (BCYC) since March 17, 2026. Bicycle Therapeutics PLC reported in an 8-K filed March 17, 2026 that Jennifer Perry was appointed Chief Operating Officer, effective March 17, 2026. Bicycle Therapeutics PLC is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Bicycle Therapeutics PLC includes Kevin Lee (CEO and Board Member), Felix J. Baker, Ph.D. (Chairman and Board Member), Pierre Legault (Chairman) and 7 others.

“On March 11, 2026, the Company's Board of Directors appointed Jennifer Perry, Pharm.D. as Chief Operating Officer, effective as of March 17, 2026 (the "Transition Date").”

Bicycle Therapeutics PLC Form 8-K, filed March 17, 2026 · Read the filing

Affiliation history

Bicycle Therapeutics PLC (BCYC)
COO

SEC 8-K

Current
2026-03-17–present

Company network

Bicycle Therapeutics PLC

BCYC

Current role

Biotechnology · Healthcare

COO

2026-03-17–present

Leadership on record at Bicycle Therapeutics PLC

Kevin Lee CEO, Board Member
Felix J. Baker, Ph.D. Chairman, Board Member
Pierre Legault Chairman
Alethia Young CFO
Travis Thompson CFO, Chief Accounting Officer
Alistair Milnes COO
Jennifer Perry, Pharm.D. COO
Michael Skynner COO, CTO
Alessandro Riva, M.D. Board Member
Bosun Hau Board Member

Recent activity

Executive change Appointed: Chief Operating Officer Bicycle Therapeutics PLC (BCYC)
2026-03-17